Cinnagen   Report issue

For profit Phase 1 Phase 3
Founded: Tehran Iran (Islamic Republic of) (1994)
Status: No NME R&D (1994)

Organization Overview

First Clinical Trial
2015
NCT03172325
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cinnagen